- A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1 (vol 10, 91, 2017)Ni, Wen; Zhang, Yuqin; Zhan, Zetao; Ye, Feng; Liang, Yonghao; Huang, Jing; Chen, Keli; Chen, Longhua*; Ding, Yi*Journal of Hematology & Oncology, 2023, 16(1): 51.
- IL-35 expression in hepatocellular carcinoma cells is associated with tumor progressionLong Jun; Guo Hongyan; Cui Shichang; Zhang Haiyan; Liu Xinmin; Li Danning; Han Zimeng; Xi Linfeng; Kou Wenyi; Xu Jiangnan; Li Tao Sheng; Ding YaozhongONCOTARGET, 2016, 7(29): 45678-45686.
- MicroRNA-30a-3p acts as a tumor suppressor in MHCC-97H hepatocellular carcinoma cells by targeting COX-2 (vol 12, pg 3945, 2021)Yang, XueMei; Sun, JiaLing; Sun, HaiTao; Wen, Bin; Zhang, MingJia; An, HaiYan; Chen, WeiCong; Zhao, WenTing; Zhong, XiaoDan; He, ChunYu; Pang, Jie; He, SongQi*American Journal of Cancer Research, 2022, 13(14): 3593-3594.
期刊论文
LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis (vol 437, pg 56, 2018)
10阅读
